Annual Shareholders Equity
-$457.00 K
+$9.63 M+95.47%
December 31, 2023
Summary
- As of February 7, 2025, CDT annual stockholders equity is -$457.00 thousand, with the most recent change of +$9.63 million (+95.47%) on December 31, 2023.
- During the last 3 years, CDT annual shareholders equity has risen by +$5.49 million (+92.31%).
- CDT annual shareholders equity is now at all-time high.
Performance
CDT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$9.12 M
-$3.66 M-66.94%
September 29, 2024
Summary
- As of February 7, 2025, CDT quarterly stockholders equity is -$9.12 million, with the most recent change of -$3.66 million (-66.94%) on September 29, 2024.
- Over the past year, CDT quarterly shareholders equity has dropped by -$8.04 million (-743.48%).
- CDT quarterly shareholders equity is now -1895.19% below its all-time high of -$457.00 thousand, reached on December 31, 2023.
Performance
CDT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CDT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +95.5% | -743.5% |
| 3 y3 years | +92.3% | -743.5% |
| 5 y5 years | +92.3% | -743.5% |
CDT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.5% | -1895.2% | +40.8% |
| 5 y | 5-year | at high | +95.5% | -1895.2% | +40.8% |
| alltime | all time | at high | +95.5% | -1895.2% | +40.8% |
Conduit Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$9.12 M(+66.9%) |
| Jun 2024 | - | -$5.46 M(+76.3%) |
| Mar 2024 | - | -$3.10 M(+578.1%) |
| Dec 2023 | -$457.00 K | -$457.00 K(-57.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$1.08 M(-93.0%) |
| Jun 2023 | - | -$15.41 M(+23.1%) |
| Mar 2023 | - | -$12.52 M(+24.1%) |
| Dec 2022 | -$10.09 M(+69.8%) | -$10.09 M |
| Dec 2021 | -$5.94 M | - |
FAQ
- What is Conduit Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals annual shareholders equity year-on-year change?
- What is Conduit Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Conduit Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of CDT is -$457.00 K
What is the all time high annual shareholders equity for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high annual stockholders equity is -$457.00 K
What is Conduit Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, CDT annual stockholders equity has changed by +$9.63 M (+95.47%)
What is Conduit Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of CDT is -$9.12 M
What is the all time high quarterly shareholders equity for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high quarterly stockholders equity is -$457.00 K
What is Conduit Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, CDT quarterly stockholders equity has changed by -$8.04 M (-743.48%)